Novavax Inc. sell JPMorgan Chase & Co.
Start price
09.05.25
/
50%
€5.45
Target price
09.05.26
€6.24
Performance (%)
35.03%
Price
13:05
€7.36
Summary
This prediction is currently active. The SELL prediction by JPMorgan_Chase___Co_ for Novavax Inc. is trending in the completely wrong direction and now has a performance of 35.03%. This prediction currently runs until 09.05.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | -9.074% | -9.074% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $9.00 to $7.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat